Ningbo MedicalSystem Biotechnology Co Ltd (300439) - Total Liabilities
Based on the latest financial reports, Ningbo MedicalSystem Biotechnology Co Ltd (300439) has total liabilities worth CN¥706.76 Million CNY (≈ $103.42 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 300439 net assets growth trend to track the company's year-over-year net asset growth rate.
Ningbo MedicalSystem Biotechnology Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Ningbo MedicalSystem Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Ningbo MedicalSystem Biotechnology Co Lt (300439) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Ningbo MedicalSystem Biotechnology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Ningbo MedicalSystem Biotechnology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PostNL NV
AS:PNL
|
Netherlands | €2.02 Billion |
|
Semco Technologies Sas
PA:ALSEM
|
France | €20.68 Million |
|
Zhejiang Sf Oilless Bearing Co Ltd
SHE:300817
|
China | CN¥259.79 Million |
|
Huali Industries
SHG:603038
|
China | CN¥1.23 Billion |
|
Core Laboratories NV
NYSE:CLB
|
USA | $312.58 Million |
|
DukSan Neolux Co.Ltd
KQ:213420
|
Korea | ₩236.09 Billion |
|
Grid Dynamics Holdings Inc
NASDAQ:GDYN
|
USA | $74.90 Million |
|
Aprogen KIC Inc
KO:007460
|
Korea | ₩323.51 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Ningbo MedicalSystem Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300439 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ningbo MedicalSystem Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)
The table below shows the annual total liabilities of Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥771.65 Million ≈ $112.92 Million |
-1.39% |
| 2023-12-31 | CN¥782.49 Million ≈ $114.50 Million |
-26.47% |
| 2022-12-31 | CN¥1.06 Billion ≈ $155.73 Million |
-11.49% |
| 2021-12-31 | CN¥1.20 Billion ≈ $175.96 Million |
-23.27% |
| 2020-12-31 | CN¥1.57 Billion ≈ $229.33 Million |
-33.38% |
| 2019-12-31 | CN¥2.35 Billion ≈ $344.25 Million |
+1.09% |
| 2018-12-31 | CN¥2.33 Billion ≈ $340.54 Million |
+16.84% |
| 2017-12-31 | CN¥1.99 Billion ≈ $291.46 Million |
+25.27% |
| 2016-12-31 | CN¥1.59 Billion ≈ $232.66 Million |
+897.74% |
| 2015-12-31 | CN¥159.36 Million ≈ $23.32 Million |
-22.69% |
| 2014-12-31 | CN¥206.12 Million ≈ $30.16 Million |
+26.77% |
| 2013-12-31 | CN¥162.59 Million ≈ $23.79 Million |
+26.38% |
| 2012-12-31 | CN¥128.66 Million ≈ $18.83 Million |
+88.31% |
| 2011-12-31 | CN¥68.32 Million ≈ $10.00 Million |
-- |
About Ningbo MedicalSystem Biotechnology Co Ltd
Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass… Read more